SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-122498
Filing Date
2024-04-29
Accepted
2024-04-29 16:33:07
Documents
18
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d758405d10ka.htm   iXBRL 10-K/A 430197
2 EX-10.30 d758405dex1030.htm EX-10.30 7266
3 EX-31.3 d758405dex313.htm EX-31.3 3767
4 EX-31.4 d758405dex314.htm EX-31.4 3785
  Complete submission text file 0001193125-24-122498.txt   718205

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eigr-20231231.xsd EX-101.SCH 4578
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eigr-20231231_cal.xml EX-101.CAL 659
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eigr-20231231_def.xml EX-101.DEF 17849
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20231231_lab.xml EX-101.LAB 23720
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20231231_pre.xml EX-101.PRE 19074
22 EXTRACTED XBRL INSTANCE DOCUMENT d758405d10ka_htm.xml XML 9311
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36183 | Film No.: 24891557
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)